For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
1
views
0
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease.

      Author(s):
      Publication date:
      Journal: International Journal of Chronic Obstructive Pulmonary Disease
      Publisher: Informa UK Ltd.
      Keywords: dose-finding, once-daily, trough FEV1, plasma concentration, trough FVC, pulmonary function

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Olodaterol is a novel long-acting β2-agonist with proven ≥24-hour duration of action in preclinical and clinical studies.

          Related collections

          Author and article information

          Journal
          PubMed ID:: 26316741
          PMC ID:: 4548739
          DOI:: 10.2147/COPD.S86002

          Keywords: dose-finding,once-daily,trough FEV1,plasma concentration,trough FVC,pulmonary function
          Data availability:
          Keywords: dose-finding, once-daily, trough FEV1, plasma concentration, trough FVC, pulmonary function

          Comments

          Comment on this article

          scite_